Literature DB >> 6437510

Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist.

D L Healy, H M Fraser, S L Lawson.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6437510      PMCID： PMC1443483          DOI： 10.1136/bmj.289.6454.1267

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue.

Authors:  M Filicori; D A Hall; J S Loughlin; J Rivier; W Vale; W F Crowley
Journal:  Am J Obstet Gynecol       Date:  1983-11-15       Impact factor: 8.661

2.  New prospects for luteinising hormone releasing hormone as a contraceptive and therapeutic agent.

Authors:  H M Fraser
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-09

3.  Management of pelvic endometriosis by means of intraabdominal carbon dioxide laser.

Authors:  A P Chong; M S Baggish
Journal:  Fertil Steril       Date:  1984-01       Impact factor: 7.329

4.  Leiomyomas: steroid receptor content. Variation within normal menstrual cycles.

Authors:  M R Soules; K S McCarty
Journal:  Am J Obstet Gynecol       Date:  1982-05-01       Impact factor: 8.661

5.  A miniature infuser for the pulsatile administration of LHRH.

Authors:  I A Sutherland; S White; G R Chambers; D Rothwell; P W Mason; M Tucker; H S Jacobs
Journal:  J Biomed Eng       Date:  1984-04
  5 in total
  4 in total

1.  Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.

Authors:  W H Matta; R W Shaw; R Hesp; D Katz
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

Review 2.  Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

Authors:  B J Furr; J R Woodburn
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

3.  Failure to preserve fertility in patients with Hodgkin's disease.

Authors:  J H Waxman; R Ahmed; D Smith; P F Wrigley; W Gregory; S Shalet; D Crowther; L H Rees; G M Besser; J S Malpas
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 4.  GnRH agonists and antagonists. Current clinical status.

Authors:  M Filicori; C Flamigni
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.